back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-07-17 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
CLS Therapeutics Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
147,403,443 | ||
| Filed 2015-07-17 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
Genkin, Dmitry
4 - Director of Issuer
Holder: FDS Pharma LLP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,745,449 | ||
| Filed 2015-07-17 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
Martin, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
199,803 | ||
| Filed 2015-07-17 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
OPKO Health, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
185,129,317 | ||
| Filed 2015-07-15 Tx date 2015-07-14 |
$VAC
SciVac Therapeutics Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
379,056 |